Drugs Five Years Later: Disopyramide
- 1 March 1982
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 96 (3), 337-343
- https://doi.org/10.7326/0003-4819-96-3-337
Abstract
The therapeutic spectrum of disopyramide in treating patients with ventricular and atrial arrhythmias is similar to that of the other type 1 antiarrhythmic drugs, quinidine and procainamide. Disopyramide has the potential to suppress sinus node function and must be used cautiously in patients with sick sinus syndrome. It can be used safely in patients with bundle branch block and 1st-degree or type I 2nd-degree atrioventricular block. Disopyramide may precipitate ventricular tachycardia or ventricular fibrillation. Because this drug often causes decompensation in patients with congestive heart failure, it must be used very cautiously, if at all, in such patients.Keywords
This publication has 22 references indexed in Scilit:
- The Effect of Quinidine and Other Oral Antiarrhythmic Drugs on Serum DigoxinAnnals of Internal Medicine, 1980
- Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.Circulation, 1979
- Electrophysiological effects of disopyramide in patients with bundle branch block.Circulation, 1979
- Disopyramide in Patients with the Wolff-Parkinson-White Syndrome and Atrial FibrillationChest, 1978
- PLACENTAL AND MILK TRANSFER OF DISOPYRAMIDE AND METABOLITES1978
- ORAL DISOPYRAMIDE FOR THE PREVENTION OF ARRHYTHMIAS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ADMITTED TO OPEN WARDSThe Lancet, 1977
- Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.Heart, 1977
- EFFECTS OF DISOPYRAMIDE ON ELECTROPHYSIOLOGIC PROPERTIES OF CANINE CARDIAC PURKINJE-FIBERS1977
- Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.Circulation Research, 1975
- PHARMACOLOGY OF A NEW ANTIARRHYTHMIC AGENT, GAMMA-DIISOPROPYLAMINO-ALPHA-PHENYL-ALPHA-(2-PYRIDYL)-BUTYRAMIDE (SC-7031)1962